Literature DB >> 29795714

The Role of Matrix Metalloproteinase-3 In the Development of Atherosclerosis and Cardiovascular Events.

Krintus Magdalena1, Kuligowska Magdalena1, Sypniewska Grazyna1.   

Abstract

The matrix metalloproteinases are a family of peptidase enzymes responsible for the degradation of extracellular matrix (ECM). Alterations in the structure and composition of the ECM play a key role in the atherogenic process. Recent data suggest the important role of MMPs in the development of atherosclerosis and future cardiovascular events. Expressed at low levels in normal tissue, MMPs are upregulated in remodeling processes. Matrix metalloproteinase-3 (MMP-3) is present in atherosclerotic plaques and acts in the degradation of the fibrous cap of the atheroma. Many clinical studies reported that increased MMP-3 level and also the gene polymorphism of MMP were the independent cardiovascular risk factors. MMPs represent an attractive target to prevent matrix degradation, atherosclerosis and possible cardiovascular events.

Entities:  

Keywords:  atherosclerosis; extracellular matrix; matrix metalloproteinase-3; matrix metalloproteinases; polymorphism; remodeling

Year:  2006        PMID: 29795714      PMCID: PMC5954426     

Source DB:  PubMed          Journal:  EJIFCC        ISSN: 1650-3414


  20 in total

1.  Characterization of the promoter of human extracellular matrix metalloproteinase inducer (EMMPRIN).

Authors:  Liang Liang; Terry Major; Thomas Bocan
Journal:  Gene       Date:  2002-01-09       Impact factor: 3.688

Review 2.  Matrix metalloproteinases and cardiovascular disease.

Authors:  C M Dollery; J R McEwan; A M Henney
Journal:  Circ Res       Date:  1995-11       Impact factor: 17.367

Review 3.  Plasmin and matrix metalloproteinases in vascular remodeling.

Authors:  H R Lijnen
Journal:  Thromb Haemost       Date:  2001-07       Impact factor: 5.249

Review 4.  Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly.

Authors:  Zorina S Galis; Jaikirshan J Khatri
Journal:  Circ Res       Date:  2002-02-22       Impact factor: 17.367

5.  Prognostic impact of matrix metalloproteinase gene polymorphisms in patients with heart failure according to the aetiology of left ventricular systolic dysfunction.

Authors:  Frédérique Mizon-Gérard; Pascal de Groote; Nicolas Lamblin; Xavier Hermant; Jean Dallongeville; Philippe Amouyel; Christophe Bauters; Nicole Helbecque
Journal:  Eur Heart J       Date:  2004-04       Impact factor: 29.983

6.  Genetic variations of matrix metalloproteinase-1 and -3 promoter regions and their associations with susceptibility to myocardial infarction in Japanese.

Authors:  Takefumi Nojiri; Hiroyuki Morita; Yasushi Imai; Koji Maemura; Minoru Ohno; Ken Ogasawara; Tadanori Aizawa; Akira Saito; Doubun Hayashi; Yasunobu Hirata; Takao Sugiyama; Tsutomu Yamazaki; Ryozo Nagai
Journal:  Int J Cardiol       Date:  2003-12       Impact factor: 4.164

7.  Circulating matrix metalloproteinase-1 and -3 in patients with an acute coronary syndrome.

Authors:  Teruo Inoue; Toru Kato; Kan Takayanagi; Toshihiko Uchida; Isao Yaguchi; Hirotoshi Kamishirado; Shigenori Morooka; Nobuo Yoshimoto
Journal:  Am J Cardiol       Date:  2003-12-15       Impact factor: 2.778

8.  Serum matrix metalloproteinase-3 in systemic sclerosis.

Authors:  Masatoshi Jinnin; Hironobu Ihn; Yoshihide Asano; Kenichi Yamane; Norihito Yazawa; Kunihiko Tamaki
Journal:  Arch Dermatol Res       Date:  2004-04-17       Impact factor: 3.017

9.  Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases.

Authors:  Z S Galis; G K Sukhova; R Kranzhöfer; S Clark; P Libby
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-17       Impact factor: 11.205

10.  Elevated levels of matrix metalloprotein-3 in patients with coronary aneurysm: A case control study.

Authors:  Istemihan Tengiz; Ertugrul Ercan; Emil Aliyev; Cevad Sekuri; Can Duman; Imre Altuglu
Journal:  Curr Control Trials Cardiovasc Med       Date:  2004-10-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.